ric measurement, we sometimes obtained inconsistent results after the first calibration step because of an inaccurate measurement in a low concentration range. In case there are variations in signal intensity between blood and tumor DNAs, the amount of the PCR templates can be adjusted accordingly ( Figure 2B ). In addition to simple comparison of the signal intensities in the agarose gel, a densitometric measurement is possible ( Figure 3B ). However, in general, only minor adjustments are necessary in our experience.
We used 10 µ L of each dilution for the first calibration PCR, which was quantitatively separated by gel electrophoresis. It is convenient to include several tumor DNAs, provided they can be run on the same gel as the control.
To identify DNA amplifications, PCRs are carried out with calibrated amounts of DNA. After gel electrophoresis and staining of the PCR products, amplifications are indicated by intense signals in tumor DNA in comparison to weaker signals in peripheral blood DNA. An example of a DNA amplification identified by this approach is shown in Figures 2C and  3C . As demonstrated, the signal intensities of all three DNA dilutions are stronger in the tumor DNA than in the control DNA. This serves as an internal control to ensure that the stronger signals do represent amplifications and do not result from differences in PCR efficiency or pipetting errors. If the results are not consistent for all dilutions, the experiment is to be discounted.
Recently, we used competitive PCR to analyze an extended region of gene amplification on chromosome 11q14. The results of the competitive PCR experiment were reproduced by our novel method but within significantly shorter time and with less effort. So far, we have tested more than 100 DNA samples of different tumor types for amplification using comparative PCR. The results of these experiments are in accordance with both in situ hybridization and Southern blot hybridization data. In summary, comparative PCR is an extremely reliable technique that has already been routinely used in several studies on DNA amplification.
Unlike comparable protocols such as competitive PCR, our novel method combines increased flexibility, time efficiency, reduced costs and high reproducibility. Several polymerase chain reaction (PCR) methods have been described to amplify unknown DNA fragments adjacent to known DNA regions using only one specific primer. All these methods use adaptors or tailing to add a known DNA sequence to a restriction site of the unknown DNA. The most applied PCR-based method has been developed by Arnold and Hodgson using vectorettes (1) . Other methods using a similar approach are designated as anchored PCR (3) or rapid amplification of cDNA ends (RACE; Reference 2). Inverse PCR (4,6,7) using two specific primers at both ends of a known sequence with direction to the unknown part of the DNA depends on circularization of the fragment of interest. Circularization is the most crucial step in inverse PCR, especially when used to specifically amplify fragments out of a complex mixture of restriction fragments. To enhance specificity of the above-mentioned methods, PCR products from the first round of PCR need to be re-amplified with nested primers.
We have developed a method to specifically amplify unknown DNA fragments out of a complex mixture of genomic DNA without re-amplifying. This approach is based on singlespecific-primer PCR (SSP-PCR) (5) and degradation of double-stranded (ds)DNA and has been used to identify Not I-linking clones in physical mapping of the Coxiella burnetii chromosome.
For this purpose, C. burnetiitotal DNA has been shotgun-cloned as Not I/ Eco RI fragments and sequenced. Contiguous Not I/ Eco RI fragments were identified by PCR using primers derived from the sequences of the fragments and directed to the Not I restriction site.
Fragments that could not be amplified that way (i.e., missing fragments adjacent to known Not I/ Eco RI frag26BioTechniques
Vol. 24, No. 1 (1998) Benchmark s ments) were amplified by adaptor PCR using one C. burnetii -specific and one Sau 3A adaptor primer and Sau 3A-digested C. burnetii DNA as template. Oligonucleotides (5 ′ -GAT CCG GAA TTC CCA GGC AGA G-3 ′ and 5 ′ -CTC TGC CTG GGA ATT CCG-3 ′ ) constituting Sau 3A adaptors were synthesized on a Model 381A DNA Synthesizer (PE Applied Biosystems, Weiterstadt, Germany) and diluted to 50 µ M with 1 ×TE buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 8.0). Equimolar amounts of the two oligonucleotides were incubated at 70°C, 56°C and room temperature for 30 min and stored at -70°C until use.
C. burnetii total DNA (500 ng) was completely restricted with Sau 3A (assuming that Sau 3A cuts every 256 bp, about 6 pmol of Sau 3A sites are generated on a chromosome with a size of 2 Mb) and ligated to Sau 3A adaptors (60 pmol) with 5 U T4 DNA ligase at 16°C overnight in a total volume of 100 µ L. The ligation mixture was either subjected to anion-exchange chromatography or to Amicon ® Microcon ® 100 Spin Columns (Millipore, Witten, Germany) to remove excess Sau 3A adaptors. The ligated fraction was ethanol-precipitated and dissolved in 100 µ L 1 × TE.
SSP-PCR was performed with 1 µ L of the purified ligation mixture under the following conditions: denaturation at 94°C for 15 s, annealing at 55°C for 15 s and extension at 72°C for 1 min for 40 cycles. The PCR mixture (20 µ L) consisted of reaction buffer (50 mM Tris-HCl, pH 9.0, 20 mM ammonium sulfate), 1.5 mM MgCl 2 , 0.2 U Tfl polymerase (Biozym, Hameln, Germany), 100 µ M each dNTP and 0.5 µ M C. burnetii -specific primer.
Reaction conditions for exonuclease III digestion of dsDNA (50 mM TrisHCl, pH 8.0, 5 mM MgCl 2 ) were adapted by adding 3.8 µ L 25 mM MgCl 2 and 1.2 µ L 200 mM Tris-HCl (pH 8.0) to the PCR mixture. dsDNA was digested by adding 1 U of exonuclease III and incubating this mixture at 37°C for 10 min. Subsequently, exonuclease III was inactivated by heating the solution to 70°C for 10 min. To remove primers, nucleotides and salt, the solution was diluted to 300 µ L with double-distilled water and concentrated to 5-10 µ L using Microcon 100 Spin Columns.
The exonuclease III digestion mixture (1 µ L) was subjected to doublestranded PCR using one C. burnetiispecific and one adaptor primer at a final concentration of 1 µ M under the same cycle conditions as for SSP-PCR except for 35 cycles (Figure 1 ). To verify its correctness, the double-stranded PCR product was restricted with Not I (Amersham-Buchler, Braunschweig, Germany). The PCR mixture (7.5 µ L), 2 µ L Universal Buffer (Stratagene, La Jolla, CA, USA) and 0.5 µ L Not I (4 U) were incubated at 37°C for 1 h and analyzed on a 1.5% agarose gel.
The gel-purified PCR product was sequenced using the C. burnetii -specific primer and the adaptor primer. Sequence data were used to construct a C. burnetii -specific primer derived from the formerly unknown DNA fragment. Proximity of the Not I/ Eco RI fragment to the unknown fragment was proved by PCR with two C. burnetii -specific primers, one from the Not I/ Eco RI fragment and one from the unknown fragment, and with C. burnetii total DNA as template. The identity of the PCR product was verified as described above.
In conclusion, the described method can be applied to amplify unknown DNA fragments out of a complex mixture of restriction fragments. The two decisive steps of this method are the enrichment of specific product by SSP-PCR and the removal of dsDNA by exonuclease III while retaining the specific single-stranded DNA. Thus, there is no background dsDNA that might give rise to unspecific PCR products. Moreover, with the presented method, only two primers are needed, and the PCR product does not need to be reamplified. The method is quite simple to perform, avoiding the tedious and time-consuming process of screening DNA libraries for overlapping clones. It can also be applied to chromosome walking projects to complete genes from which sequence data are only partially available or to screen sites for the insertion of transposons, insertion elements or pathogenicity islands. 
